Consensus and controversies regarding the treatment of rhabdomyosarcoma

Scott C. Borinstein, Diana Steppan, Masanori Hayashi, David M. Loeb, Michael S. Isakoff, Odion Binitie, Andrew S. Brohl, Julia A. Bridge, Mark Stavas, Eric T. Shinohara, William H. Meyer, Damon R. Reed, Lars M. Wagner

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Optimal treatment of rhabdomyosarcoma (RMS) requires multidisciplinary approach, incorporating chemotherapy with local control. Although current therapies are built on cooperative group trials, a comprehensive standard of care to guide clinical decision making has been lacking, especially for relapsed patients. Therefore, we assembled a panel of pediatric and adolescent and young adult sarcoma experts to develop treatment guidelines for managing RMS and to identify areas in which further research is needed. We created algorithms incorporating evidence-based care for patients with RMS, emphasizing the importance of clinical trials and close integration of all specialties involved in the care of these patients.

Original languageEnglish (US)
Article numbere26809
JournalPediatric Blood and Cancer
Volume65
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Rhabdomyosarcoma
Patient Care
Standard of Care
Sarcoma
Young Adult
Therapeutics
Clinical Trials
Guidelines
Pediatrics
Drug Therapy
Research

Keywords

  • adolescent and young adult
  • chemotherapy
  • pediatric
  • rhabdomyosarcoma
  • sarcoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Borinstein, S. C., Steppan, D., Hayashi, M., Loeb, D. M., Isakoff, M. S., Binitie, O., ... Wagner, L. M. (2018). Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatric Blood and Cancer, 65(2), [e26809]. https://doi.org/10.1002/pbc.26809

Consensus and controversies regarding the treatment of rhabdomyosarcoma. / Borinstein, Scott C.; Steppan, Diana; Hayashi, Masanori; Loeb, David M.; Isakoff, Michael S.; Binitie, Odion; Brohl, Andrew S.; Bridge, Julia A.; Stavas, Mark; Shinohara, Eric T.; Meyer, William H.; Reed, Damon R.; Wagner, Lars M.

In: Pediatric Blood and Cancer, Vol. 65, No. 2, e26809, 01.02.2018.

Research output: Contribution to journalReview article

Borinstein, SC, Steppan, D, Hayashi, M, Loeb, DM, Isakoff, MS, Binitie, O, Brohl, AS, Bridge, JA, Stavas, M, Shinohara, ET, Meyer, WH, Reed, DR & Wagner, LM 2018, 'Consensus and controversies regarding the treatment of rhabdomyosarcoma', Pediatric Blood and Cancer, vol. 65, no. 2, e26809. https://doi.org/10.1002/pbc.26809
Borinstein SC, Steppan D, Hayashi M, Loeb DM, Isakoff MS, Binitie O et al. Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatric Blood and Cancer. 2018 Feb 1;65(2). e26809. https://doi.org/10.1002/pbc.26809
Borinstein, Scott C. ; Steppan, Diana ; Hayashi, Masanori ; Loeb, David M. ; Isakoff, Michael S. ; Binitie, Odion ; Brohl, Andrew S. ; Bridge, Julia A. ; Stavas, Mark ; Shinohara, Eric T. ; Meyer, William H. ; Reed, Damon R. ; Wagner, Lars M. / Consensus and controversies regarding the treatment of rhabdomyosarcoma. In: Pediatric Blood and Cancer. 2018 ; Vol. 65, No. 2.
@article{5bb08da8e7d4430a8010589f67697dfa,
title = "Consensus and controversies regarding the treatment of rhabdomyosarcoma",
abstract = "Optimal treatment of rhabdomyosarcoma (RMS) requires multidisciplinary approach, incorporating chemotherapy with local control. Although current therapies are built on cooperative group trials, a comprehensive standard of care to guide clinical decision making has been lacking, especially for relapsed patients. Therefore, we assembled a panel of pediatric and adolescent and young adult sarcoma experts to develop treatment guidelines for managing RMS and to identify areas in which further research is needed. We created algorithms incorporating evidence-based care for patients with RMS, emphasizing the importance of clinical trials and close integration of all specialties involved in the care of these patients.",
keywords = "adolescent and young adult, chemotherapy, pediatric, rhabdomyosarcoma, sarcoma",
author = "Borinstein, {Scott C.} and Diana Steppan and Masanori Hayashi and Loeb, {David M.} and Isakoff, {Michael S.} and Odion Binitie and Brohl, {Andrew S.} and Bridge, {Julia A.} and Mark Stavas and Shinohara, {Eric T.} and Meyer, {William H.} and Reed, {Damon R.} and Wagner, {Lars M.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/pbc.26809",
language = "English (US)",
volume = "65",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Consensus and controversies regarding the treatment of rhabdomyosarcoma

AU - Borinstein, Scott C.

AU - Steppan, Diana

AU - Hayashi, Masanori

AU - Loeb, David M.

AU - Isakoff, Michael S.

AU - Binitie, Odion

AU - Brohl, Andrew S.

AU - Bridge, Julia A.

AU - Stavas, Mark

AU - Shinohara, Eric T.

AU - Meyer, William H.

AU - Reed, Damon R.

AU - Wagner, Lars M.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Optimal treatment of rhabdomyosarcoma (RMS) requires multidisciplinary approach, incorporating chemotherapy with local control. Although current therapies are built on cooperative group trials, a comprehensive standard of care to guide clinical decision making has been lacking, especially for relapsed patients. Therefore, we assembled a panel of pediatric and adolescent and young adult sarcoma experts to develop treatment guidelines for managing RMS and to identify areas in which further research is needed. We created algorithms incorporating evidence-based care for patients with RMS, emphasizing the importance of clinical trials and close integration of all specialties involved in the care of these patients.

AB - Optimal treatment of rhabdomyosarcoma (RMS) requires multidisciplinary approach, incorporating chemotherapy with local control. Although current therapies are built on cooperative group trials, a comprehensive standard of care to guide clinical decision making has been lacking, especially for relapsed patients. Therefore, we assembled a panel of pediatric and adolescent and young adult sarcoma experts to develop treatment guidelines for managing RMS and to identify areas in which further research is needed. We created algorithms incorporating evidence-based care for patients with RMS, emphasizing the importance of clinical trials and close integration of all specialties involved in the care of these patients.

KW - adolescent and young adult

KW - chemotherapy

KW - pediatric

KW - rhabdomyosarcoma

KW - sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85038565295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038565295&partnerID=8YFLogxK

U2 - 10.1002/pbc.26809

DO - 10.1002/pbc.26809

M3 - Review article

C2 - 28905489

AN - SCOPUS:85038565295

VL - 65

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 2

M1 - e26809

ER -